Analysis of the Metabolic Characteristics of Serum Samples in Patients With Multiple Myeloma
Du, Haiwei, Wang, Linyue, Liu, Bo, Wang, Jinying, Su, Haoxiang, Zhang, Ting, Huang, Zhongxia
Published in Frontiers in pharmacology (22.08.2018)
Published in Frontiers in pharmacology (22.08.2018)
Get full text
Journal Article
Serum Abnormal Metabolites for Evaluating Therapeutic Response and Prognosis of Patients With Multiple Myeloma
Wei, Yujun, Wang, Jinying, Chen, Fei, Li, Xin, Zhang, Jiajia, Shen, Man, Tang, Ran, Huang, Zhongxia
Published in Frontiers in oncology (28.02.2022)
Published in Frontiers in oncology (28.02.2022)
Get full text
Journal Article
Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial
Xia, Zhongjun, Leng, Yun, Fang, Baijun, Liang, Yang, Li, Wei, Fu, Chengcheng, Yang, Linhua, Ke, Xiaoyan, Jiang, Hua, Weng, Jianyu, Liu, Li, Zhao, Yaozhong, Zhang, Xuejun, Huang, Zhongxia, Liu, Aichun, Shi, Qingzhi, Gao, Yuhuan, Chen, Xiequn, Pan, Ling, Cai, Zhen, Wang, Zhao, Wang, Yafei, Fan, Yaqun, Hou, Ming, Ma, Yigai, Hu, Jianda, Liu, Jing, Zhou, Jianfeng, Zhang, Xiaohong, Meng, Haitao, Lu, Xuzhang, Li, Fei, Ren, Hanyun, Huang, Bintao, Shao, Zonghong, Zhou, Hebing, Hu, Yu, Yang, Shifang, Zheng, Xiangjun, Wei, Peng, Pang, Hongyan, Yu, Wei, Liu, Yuzhang, Gao, Sujun, Yan, Lingzhi, Ma, Yanping, Jing, Hongmei, Du, Juan, Ling, Wei, Zhang, Jingyi, Sui, Weiwei, Wang, Fuxu, Li, Xin, Chen, Wenming
Published in BMC cancer (14.10.2023)
Published in BMC cancer (14.10.2023)
Get full text
Journal Article
Ixazomib‐based maintenance therapy after bortezomib‐based induction in patients with multiple myeloma not undergoing transplantation: A real‐world study
Shen, Man, Zhang, Jiajia, Tang, Ran, Wang, Yuhao, Zhan, Xiaokai, Fan, Sibin, Huang, Zhongxia, Zhong, Yuping, Li, Xin
Published in Cancer medicine (Malden, MA) (01.06.2022)
Published in Cancer medicine (Malden, MA) (01.06.2022)
Get full text
Journal Article
Phase Ⅱ open-label study of recombinant circularly permuted TRAIL as a single-agent treatment for relapsed or refractory multiple myeloma
Leng, Yun, Qiu, Lugui, Hou, Jian, Zhao, Yaozhong, Zhang, Xuejun, Yang, Shifang, Xi, Hao, Huang, Zhongxia, Pan, Ling, Chen, Wenming
Published in Ai zheng (08.09.2016)
Published in Ai zheng (08.09.2016)
Get full text
Journal Article
P925: PHASE 1 TRIAL OF ANTI‐CD38 MONOCLONAL ANTIBODY CM313 IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA OR LYMPHOMA
Chen, Wenming, Huang, Zhongxia, Fang, Baijun, Song, Yuqin, Jing, Hongmei, Xia, Zhongjun, Cai, Zhen, An, Gang, Zhou, Huixing, Liu, Nian, LI, Xin, Liu, Yuzhang, Ping, Lingyan, Wan, Wei, Chen, Xiaoqin, He, Jingsong, Xu, Yan
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
At least two high-risk cytogenetic abnormalities indicate the inferior outcomes for newly diagnosed multiple myeloma patients: a real-world study in China
Shen, Man, Yang, Guangzhong, Li, Xin, Geng, Chuanying, Huang, Zhongxia, Chen, Wenming
Published in Leukemia & lymphoma (15.10.2021)
Published in Leukemia & lymphoma (15.10.2021)
Get full text
Journal Article
Detection of lenalidomide metabolites in urine to discover drug-resistant compounds
Zhan, Xiaokai, Liu, Xikun, Rang, Li, Shen, Man, Zhang, Jiajia, Tang, Ran, Fan, Sibin, Zhao, Fengyi, Li, Xin, Zhang, Xiaoying, Huang, Zhongxia, Zhang, Sen
Published in Clinica chimica acta (15.01.2024)
Published in Clinica chimica acta (15.01.2024)
Get full text
Journal Article
Clinical Analysis of Cardiac Involvement in 53 Patients With Multiple Myeloma Coexistent With Light Chain Amyloidosis
Yu, Yuanyuan, Huang, Zhongxia, Hu, Wanli, Li, Xin, Shen, Man, Zhang, Jiajia, Tang, Ran, Chen, Shilun, Chen, Wenming
Published in Clinical lymphoma, myeloma and leukemia (01.08.2020)
Published in Clinical lymphoma, myeloma and leukemia (01.08.2020)
Get full text
Journal Article
Doxycycline Combined with Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Patients with Mayo 2004 Stage II-III Light-Chain Amyloidosis: A Randomized Controlled Multicenter Study
Shen, Kaini, Dong, Yujun, Fu, Weijun, Wu, Yu, Huang, Zhongxia, Wei, Yongqiang, Li, Chunrui, Sun, Chunyan, Huang, Wenrong, Wang, Huihan, Zhang, Congli, Miao, Huilei, Zhang, Lu, Cao, Xinxin, Zhou, Daobin, Li, Jian
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Cytogenetic abnormality in patients with multiple myeloma analyzed by fluorescent in situ hybridization
Hu, Ying, Chen, Wenming, Chen, Shilun, Huang, Zhongxia
Published in OncoTargets and therapy (01.01.2016)
Published in OncoTargets and therapy (01.01.2016)
Get full text
Journal Article
A multicenter, open‐label phase II study of recombinant CPT (Circularly Permuted TRAIL) plus thalidomide in patients with relapsed and refractory multiple myeloma
Geng, Chuanying, Hou, Jian, Zhao, Yaozhong, Ke, Xiaoyan, Wang, Zhao, Qiu, Lugui, Xi, Hao, Wang, Fuxu, Wei, Na, Liu, Yan, Yang, Shifang, Wei, Peng, Zheng, Xiangjun, Huang, Zhongxia, Zhu, Bing, Chen, Wen‐Ming
Published in American journal of hematology (01.11.2014)
Published in American journal of hematology (01.11.2014)
Get full text
Journal Article
Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myeloma
Painuly, Utkarsh, Ramakrishnan, Vijay, Kimlinger, Teresa, Wellik, Linda, Haug, Jessica, Gonsalves, Wilson, Bi, Lintao, Huang, Zhongxia, Rajkumar, S Vincent, Kumar, Shaji
Published in Oncotarget (02.10.2018)
Published in Oncotarget (02.10.2018)
Get full text
Journal Article
P-192: Circularly permuted TRAIL (CPT) combined with Thalidomide and Dexamethasone in patients with relapsed/refractory Multiple Myeloma: a randomized, double-blind, placebo-controlled phase 3 study
Chen, Wenming, Xia, Zhongjun, Fang, Baijun, Fu, Chengcheng, Li, Wei, Yang, Linhua, Ke, Xiaoyan, Jiang, Hua, Weng, Jianyu, Liu, Li, Zhao, Yaozhong, Zhang, Xuejun, Liu, Aichun, Huang, Zhongxia, Shi, Qingzhi, Gao, Yuhuan, Chen, Xiequn, Pan, Ling, Cai, Zhen, Wang, Zhao, Wang, Yafei, Zhang, Yizhuo, fan, Yaqun, Hou, Ming, Yang, Shifang
Published in Clinical lymphoma, myeloma and leukemia (01.10.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2021)
Get full text
Journal Article
Very Low-Dose Decitabine Is Effective in Treating Intermediate or High Risk Myelodysplastic Syndrome
Li, Hongmin, Wang, Liru, Wu, Yue, Su, Li, Zhao, Hong, Zhang, Yongqing, Wang, Zhao, Huang, Dayong, Huang, Zhongxia, Wu, Xiaoxiong, Li, Xiaohong, Ye, Fang, Yu, Fan, Liu, Hui, Wang, Jingwen, Cong, Jia, Sun, Wanjun, Chen, Huiren, Wang, Jingbo, Han, Bing
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Very-Low-Dose Decitabine Is Effective in Treating Intermediate- or High-Risk Myelodysplastic Syndrome
Li, Hongmin, Wang, Liru, Wu, Yue, Su, Li, Zhao, Hong, Zhang, Yongqing, Wang, Zhao, Huang, Dayong, Huang, Zhongxia, Wu, Xiaoxiong, Li, Xiaohong, Ye, Fang, Yu, Fan, Liu, Hui, Wang, Jing-Wen, Cong, Jia, Sun, Wanjun, Chen, Hui-Ren, Wang, Jingbo, Han, Bing
Published in Acta haematologica (01.01.2017)
Published in Acta haematologica (01.01.2017)
Get more information
Journal Article
Efficacy and Safety of Dual-targeted Chimeric Antigen Receptor-T Cell Therapy in Patients with Refractory-relapsed Multiple Myeloma: a Meta-analysis
YU Haibo, ZHANG Tianyu, LI Xin, ZHANG Jiajia, SHEN Man, ZHAN Xiaokai, TANG Ran, FAN Sibin, ZHAO Fengyi, HUANG Zhongxia
Published in Zhongguo quanke yixue (01.03.2024)
Published in Zhongguo quanke yixue (01.03.2024)
Get full text
Journal Article